Steven Cohen
Point72 Asset Management
Steven Cohen, a Wharton School graduate, is considered one of the top hedge fund managers. He founded SAC Capital (later renamed Point72) in 1992. The firm has posted an annualized return of over 30%; in 2023, its flagship fund returned about 11%.
Stock Trading
All
Buys
Sells
No.
Name
Action
Shares Traded
% Change
Shares Held
Mkt Value (Date)
Report Date
C4 Therapeutics Inc (US)
CCCC
New
+8.48M
+50.00%
8.48M
$20.86M
2025-10-17
Wolfspeed Inc (US)
WOLF
New
+1.54M
+50.00%
1.54M
$47.89M
2025-10-09
Palisade Bio Inc (US)
PALI
New
+7.59M
+50.00%
7.59M
$13.43M
2025-10-06
4
Shuangdeng Group Ord Shs Class H (HK)
6960
New
+7.12M
+50.00%
7.12M
$16.84M
2025-09-24
5
Aptevo Therapeutics Inc (US)
APVO
New
+299.94K
+50.00%
299.94K
$434.92K
2025-09-16
6
Soitec Ord Shs (FR)
SOIT
Buy
+106.00K
+4.10%
2.48M
$112.71M
2025-09-16
7
1RT Acquisition Ord Shs Class A (US)
ONCH
New
+1.50M
+50.00%
1.50M
$15.68M
2025-09-12
8
Fundamental Global Ord Shs (US)
FGNX
New
+3.48M
+50.00%
3.48M
$19.08M
2025-09-05
9
Shanghai Henlius Biotech Ord Shs H (HK)
2696
Sell
-46.20K
-0.50%
7.74M
$74.91M
2025-09-05
10
KALA BIO Inc (US)
KALA
New
+469.23K
+50.00%
469.23K
$717.92K
2025-09-04
